An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia

被引：6
|
作者：
Dursun, S [1 ]
机构：
[1] Univ Manchester, Neurosci & Psychiat Unit, Manchester M13 9PT, Lancs, England
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2005年 / 19卷 / 05期
关键词：
D O I：
10.1177/0269881105057347
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [21] Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review
    Canas, Fernando
    Moeller, Hans-Juergen
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (05) : 683 - 697
  • [22] Guidelines on long-acting injectable atypical antipsychotics for first-episode schizophrenia
    Azorin, J. -M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2013, 39 : S121 - S123
  • [23] Safety of the first long-acting atypical antipsychotic
    Llorca, PM
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S99 - S99
  • [24] EFFECTIVENESS OF A LONG-ACTING INJECTABLE ANTIPSYCHOTIC IN FIRST-EPISODE SCHIZOPHRENIA: THE EONKCS STUDY
    Chiliza, Bonginkosi
    Asmal, Laila
    Emsley, Robin
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S305 - S306
  • [25] Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
    Kane, John M.
    McEvoy, Joseph P.
    Correll, Christoph U.
    Llorca, Pierre-Michel
    CNS DRUGS, 2021, 35 (11) : 1189 - 1205
  • [26] Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy
    Alphs, Larry
    Nasrallah, Henry A.
    Bossie, Cynthia A.
    Fu, Dong-Jing
    Gopal, Srihari
    Hough, David
    Turkoz, Ibrahim
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (04) : 202 - 209
  • [27] Effects of aripiprazole long-acting injectable antipsychotic on hospitalization in recent-onset schizophrenia
    Karlovic, Dalibor
    Silic, Ante
    Crnkovic, Danijel
    Peitl, Vjekoslav
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2021, 36 (02)
  • [28] Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians
    Citrome, Leslie
    Belcher, Emily
    Stacy, Sylvie
    Suett, Mark
    Mychaskiw, Marko
    Salinas, Gregory D.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 111 - 123
  • [29] Long-Acting Injectable Antipsychotic Medications in Patients With Comorbid Schizophrenia and Substance Use Disorders
    Green, Alan I.
    JOURNAL OF DUAL DIAGNOSIS, 2012, 8 (01) : 62 - 63
  • [30] Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
    John M. Kane
    Joseph P. McEvoy
    Christoph U. Correll
    Pierre-Michel Llorca
    CNS Drugs, 2021, 35 : 1189 - 1205
12345